Endothelial Hematopoietic Transition
Endothelial Hematopoietic Transition - Related Videos
09:05
In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
0 Views •
Cited by 7 •
2016
A primary culture of bovine corneal endothelial cells was used to investigate the mechanism of corneal endothelial-mesenchymal transition. Furthermore, a rat corneal endothelium cryoinjury model was used to demonstrate corneal endothelial-mesenchymal transition in vivo.
14:37
Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
0 Views •
Cited by 19 •
2017
Here, we present human pluripotent stem cell (hPSC) culture protocols, used to differentiate hPSCs into CD34+ hematopoietic progenitors. This method uses stage-specific manipulation of canonical WNT signaling to specify cells exclusively to either the definitive or primitive hematopoietic program.
02:31
Phase Transitions
0 Views •
2020
Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to occupy...
08:56
Isolation of Murine Embryonic Hemogenic Endothelial Cells
0 Views •
Cited by 11 •
2016
Hematopoietic stem and progenitor cells (HSPC) derive from specialized (hemogenic) endothelial cells during development, yet little is known about the process by which some endothelial cells specify to become blood forming. We demonstrate a flow-cytometry based method allowing simultaneous isolation of hemogenic endothelial cells and HSPC from murine embryonic tissues.
08:36
Modified ES / OP9 Co-Culture Protocol Provides Enhanced Characterization of Hematopoietic Progeny
0 Views •
Cited by 12 •
2011
mStrawberry OP9 cells allow for complete evaluation of all ES-derived progeny from co-culture.
FAQs
RUNX1 acts as a central molecular regulator during EHT. Its activity is associated with the conversion of specialized endothelial cells toward blood-forming identity, making it a key point for investigating how definitive hematopoiesis begins. In developmental studies, examining RUNX1-related changes helps connect altered gene expression with the emergence of hematopoietic cells.
The cellular transformation includes coordinated changes in gene expression, shape, and adhesion. Endothelial cells round up rather than retaining their original vessel-associated form, then bud from the vessel wall into the lumen. Tracking these physical changes helps investigators recognize the progression from an endothelial state toward an emerging hematopoietic cell.
EHT occurs during embryogenesis, when definitive blood production begins and the foundation of the hematopoietic system is established. Studying this developmental window helps explain how hematopoietic stem and progenitor cells arise. It therefore links early embryonic cell behavior with the later formation of blood-producing capacity.
A useful investigation should follow several connected indicators rather than a single feature. Researchers can examine changes in endothelial gene expression, cell shape, adhesion, rounding, and budding into the lumen. Considering these events together provides a more complete picture of the cellular conversion and helps relate molecular changes to visible developmental behavior.
Endothelial Hematopoietic Transition provides developmental context for understanding how hematopoietic stem and progenitor cells arise. By analyzing the conversion of specialized endothelial cells and the emergence of blood-forming cells, researchers can investigate the earliest steps of blood development. This knowledge supports efforts focused on understanding blood formation and stem cell generation.
Research on EHT has relevance to blood disorders, stem cell generation, and regenerative medicine. Its value comes from clarifying how definitive blood production begins and how blood-forming cells emerge during development. These insights can guide investigations into abnormal blood development and inform approaches that seek to generate or replace blood-related cells.